CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Update

CellaVision AB (publ) (OTCMKTS:CLVSF) saw a large growth in short interest in September. As of September 30th, there was short interest totaling 4,200 shares, a growth of 61.5% from the September 15th total of 2,600 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ? days. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ? days.

CellaVision AB (publ) Stock Performance

CellaVision AB (publ) stock opened at $19.28 on Wednesday. CellaVision AB has a 12-month low of $19.28 and a 12-month high of $19.91. The firm has a 50 day simple moving average of $19.28 and a 200-day simple moving average of $19.28.

CellaVision AB (publ) Company Profile

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.